Lilly Doubles Down On Novel Pain Drugs With Confo Therapeutics Deal
Adds To Three Non-Opioid Candidates In Pipeline
Belgium’s Confo Therapeutics gains its first big pharma partner in the field of non-opioid pain treatment, giving the big pharma will test its master protocol approach as it put its R&D muscle behind this major area of unmet need.
